Authors: Andrew Skolnick
Publish Date: 1991/04/24
Volume: 265, Issue: 16, Pages: 2041-2042
Abstract
Although the license application proposes its use for treating bone marrow transplant patients with steroidresistant GvHD the antibody—toxin conjugate also shows promise for treating autoimmune diseases such as rheumatoid arthritis and type I diabetes as well as certain hematologic malignancies says Vera S Byers MD PhD who is director
Keywords: